MARKET

PSNL

PSNL

Personalis
NASDAQ
16.46
-0.11
-0.66%
After Hours: 16.38 -0.08 -0.49% 19:30 09/25 EDT
OPEN
16.74
PREV CLOSE
16.57
HIGH
16.77
LOW
16.38
VOLUME
1.02M
TURNOVER
--
52 WEEK HIGH
18.89
52 WEEK LOW
4.955
MARKET CAP
1.76B
P/E (TTM)
-15.0898
1D
5D
1M
3M
1Y
5Y
1D
Top Personalis Executive Makes Notable Insider Move With Recent Stock Sale
TipRanks · 3d ago
Weekly Report: what happened at PSNL last week (0914-0918)?
Weekly Report · 5d ago
Noteworthy ETF Outflows: ARKG, TXG, PSNL, GH
NASDAQ · 09/16 15:03
Weekly Report: what happened at PSNL last week (0907-0911)?
Weekly Report · 09/14 10:15
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI
Seeking Alpha · 09/07 11:10
Weekly Report: what happened at PSNL last week (0831-0904)?
Weekly Report · 09/07 10:09
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels - Heard on the Street
The Wall Street Journal · 09/04 09:30
Tempus AI upgraded at Piper Sandler on growth drivers
Seeking Alpha · 09/01 15:49
More
About PSNL
Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Webull offers Personalis Inc stock information, including NASDAQ: PSNL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSNL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSNL stock methods without spending real money on the virtual paper trading platform.